IMIST


Vue normale Vue MARC vue ISBD

Medicinal chemistry of anticancer drugs

par Avendano, Carmen.
Autres auteurs : Menendez, J. Carlos.
Mention d'édition :1st ed. Publié par : Elsevier Science (Amsterdam ; Boston) Détails physiques : 442 p. d24 cm. ISBN :0444528245 (hardcover); 9780444528247 (hardcover). Année : 2008
Tags de cette bibliothèque : Pas de tags pour ce titre. Connectez-vous pour ajouter des tags.
    Évaluation moyenne : 0.0 (0 votes)
Type de document Site actuel Cote Statut Date de retour prévue Code à barres Réservations
Livre La bibliothèque des Sciences Médicales et Pharmaceutiques
616.994 AVE (Parcourir l'étagère) Disponible 0000000013104
Total des réservations: 0
Survol La bibliothèque des Sciences Médicales et Pharmaceutiques Étagères Fermer l'étagère
616.994 ALI VOL.2 The cancer handbook / 616.994 AME Actualités 616.994 AND Multiple myeloma 616.994 AVE Medicinal chemistry of anticancer drugs 616.994 BER Practical gynecologic oncology. 616.994 BER Practical gynecologic oncology. 616.994 BIG Cancer

Antitumour chemotherapy is nowadays a very active field of research, and a huge amount of information on the topic is generated every year. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book addresses the need for an updated treatment from the point of view of medicinal chemistry and drug design. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells. These therapies are in their infancy, but they hold promise of more effective therapies with fewer side effects. Resistance to antitumour drugs is another important but normally neglected field. The focus of Medicinal Chemistry of Anticancer Drugs is on the mechanism of action of antitumour drugs from the molecular point of view and on the relationship between chemical structure and chemical and biochemical reactivity of antitumour agents, aiming at the rationalization of the action of this type of drugs, which would allow the design of new active structures. * Presents information in a clear and concise way using a large number of figures * Historical background provides insights on how the process of drug discovery in the anticancer field has evolved * Extensive references to primary literature.

Il n'y a pas de commentaire pour ce document.

pour proposer un commentaire.
© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha